FI102282B1 - Menetelmä O-glykosyloidun IGF-1:n valmistamiseksi - Google Patents

Menetelmä O-glykosyloidun IGF-1:n valmistamiseksi

Info

Publication number
FI102282B1
FI102282B1 FI910795A FI910795A FI102282B1 FI 102282 B1 FI102282 B1 FI 102282B1 FI 910795 A FI910795 A FI 910795A FI 910795 A FI910795 A FI 910795A FI 102282 B1 FI102282 B1 FI 102282B1
Authority
FI
Finland
Prior art keywords
igf
glycosylated
preparing
glycosylated igf
expressed
Prior art date
Application number
FI910795A
Other languages
English (en)
Swedish (sv)
Other versions
FI102282B (fi
FI910795A0 (fi
Inventor
Anna Skottner-Lundin
Linda Fryklund
Paer Gellerfors
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of FI910795A0 publication Critical patent/FI910795A0/fi
Application granted granted Critical
Publication of FI102282B1 publication Critical patent/FI102282B1/fi
Publication of FI102282B publication Critical patent/FI102282B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Emergency Medicine (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI910795A 1988-08-20 1991-02-19 Menetelmä O-glykosyloidun IGF-1:n valmistamiseksi FI102282B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB888819826A GB8819826D0 (en) 1988-08-20 1988-08-20 Glycosylated igf-1
GB8819826 1988-08-20
EP8900972 1989-08-17
PCT/EP1989/000972 WO1990002198A1 (en) 1988-08-20 1989-08-17 O-glycosylated igf-1

Publications (3)

Publication Number Publication Date
FI910795A0 FI910795A0 (fi) 1991-02-19
FI102282B1 true FI102282B1 (fi) 1998-11-13
FI102282B FI102282B (fi) 1998-11-13

Family

ID=10642464

Family Applications (1)

Application Number Title Priority Date Filing Date
FI910795A FI102282B (fi) 1988-08-20 1991-02-19 Menetelmä O-glykosyloidun IGF-1:n valmistamiseksi

Country Status (15)

Country Link
US (1) US5273966A (fi)
EP (2) EP0360411B1 (fi)
JP (1) JP2543998B2 (fi)
AT (1) ATE109206T1 (fi)
AU (1) AU623675B2 (fi)
CA (1) CA1335802C (fi)
DE (1) DE68917061T2 (fi)
DK (1) DK175360B1 (fi)
ES (1) ES2060778T3 (fi)
FI (1) FI102282B (fi)
GB (1) GB8819826D0 (fi)
IE (1) IE65096B1 (fi)
NO (1) NO180636C (fi)
NZ (1) NZ230383A (fi)
WO (1) WO1990002198A1 (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8920381D0 (en) * 1989-09-08 1989-10-25 Greater Glasgow Health Board Treatment of insulin-resistant diabetes
US5612198A (en) * 1990-09-04 1997-03-18 The Salk Institute Production of insulin-like growth factor-1 in methylotrophic yeast cells
US5231178A (en) * 1991-01-16 1993-07-27 The Salk Institute Biotechnology/Industrial Associates, Inc. Method for the purification of intact, correctly-folded insulin-like growth factor-1
CA2105064A1 (en) * 1991-04-01 1992-10-02 Martin Anthony Gleeson Genes which influence pichia proteolytic activity, and uses therefor
DE59305396D1 (de) * 1992-12-02 1997-03-20 Hoechst Ag Verfahren zur Gewinnung von Proinsulin mit korrekt verbundenen Cystinbrücken
SE9402332D0 (sv) * 1994-07-01 1994-07-01 Pharmacia Ab Igf-1
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
US8343918B2 (en) * 2006-06-09 2013-01-01 Novartis Ag Stabilized insulin-like growth factor polypeptides
US20120213728A1 (en) * 2009-10-30 2012-08-23 Merck Granulocyte-colony stimulating factor produced in glycoengineered pichia pastoris
US20100172865A1 (en) * 2010-03-18 2010-07-08 Shantha Totada R Methods of enhancing hair growth
ES2674567T3 (es) 2010-05-21 2018-07-02 Merrimack Pharmaceuticals, Inc. Proteínas de fusión biespecíficas
KR20160091888A (ko) 2013-10-02 2016-08-03 노파르티스 아게 요법에 사용하기 위한 인슐린-유사 성장 인자 모방체
JP7005019B2 (ja) 2015-10-02 2022-02-04 シルバー・クリーク・ファーマシューティカルズ・インコーポレイテッド 組織修復のための二重特異性治療用タンパク質

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0561137B1 (en) * 1983-04-25 2002-07-03 Chiron Corporation Hybrid DNA Synthesis of Mature Insulin-like Growth Factors

Also Published As

Publication number Publication date
WO1990002198A1 (en) 1990-03-08
NO910669D0 (no) 1991-02-19
DE68917061T2 (de) 1994-11-17
NO910669L (no) 1991-02-19
GB8819826D0 (en) 1988-09-21
CA1335802C (en) 1995-06-06
EP0360411A1 (en) 1990-03-28
JPH05505514A (ja) 1993-08-19
IE892652L (en) 1990-02-20
ES2060778T3 (es) 1994-12-01
DE68917061D1 (de) 1994-09-01
JP2543998B2 (ja) 1996-10-16
FI102282B (fi) 1998-11-13
FI910795A0 (fi) 1991-02-19
DK29491D0 (da) 1991-02-20
NZ230383A (en) 1992-01-29
EP0360411B1 (en) 1994-07-27
US5273966A (en) 1993-12-28
AU4051889A (en) 1990-03-23
DK175360B1 (da) 2004-09-13
DK29491A (da) 1991-04-19
IE65096B1 (en) 1995-10-04
AU623675B2 (en) 1992-05-21
ATE109206T1 (de) 1994-08-15
NO180636C (no) 1997-05-21
EP0429502A1 (en) 1991-06-05
NO180636B (no) 1997-02-10

Similar Documents

Publication Publication Date Title
DK0402300T3 (da) Fremstilling i bakterier af gær og hæmoglobin og analoger dertil
DE68916385D1 (de) Stabilisierte Formulierungen mit hydrohoben Proteinen.
ATE122357T1 (de) Polypeptide mit hormonwachstumsbefreiender wirkung.
AU6733487A (en) Mammalian interleukin-4
FI893702A0 (fi) Foerfarande foer mikrobiologisk framstaellning av humant serumalbumin och andra heterologa proteiner ur jaest.
FI102282B1 (fi) Menetelmä O-glykosyloidun IGF-1:n valmistamiseksi
ATE56728T1 (de) Neue polypeptide mit alpha-amylase-hemmender wirkung, verfahren zu deren herstellung, deren verwendung und pharmazeutische praeparate.
DK0454898T3 (da) Glycosaminoglycan-modificeret protein, fremgangsmåde til fremstilling af proteinet, farmaceutiske præparater indeholdende proteinet samt anvendelse af proteinet
DE68922917T2 (de) KEX2-Endoprotease und Verfahren zu ihrer Herstellung.
IL80562A0 (en) Recombinant human lysozyme,its preparation by recombinant dna technology and pharmaceutical compositions containing it
DE3650790D1 (de) Menschlisches Interferon-Beta 2A zur Verwendung als Arzneimittel
EP0390849A4 (en) Methyl cellulose pharmaceutical composition

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: PHARMACIA & UPJOHN AKTIEBOLAG

HC Name/ company changed in application

Owner name: PHARMACIA & UPJOHN AKTIEBOLAG

MA Patent expired